For patients not benefiting from neonatal screening with equivocal ST, investigating CFTR function (NPD or intestinal current measurement) is advised, leading to classification as CFTR-Related Metabolic Syndrome (CRMS) if the genetic test remains inconclusive [29]. The gene discussed is CFTR; the disease is CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis.